Monitoring of Allergic and Asthmatic Symptoms in Patients Taking Dietary Supplements Joalis Bambi Bronchi and Joalis Bambi Analerg
NCT ID: NCT01684137
Last Updated: 2012-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Improving quality of life observed in the visual analogue scale (VAS).
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Joalis Bambi Bronchi & Joalis Bambi Analerg
10 days, 2 times per day 2,5/5 ml
Joalis Bambi Analerg
Joalis Bambi Bronchi
Placebo & Placebo
10 days, 2 times per day 2,5/5 ml
Placebo
Sugar pill manufactured to mimic Joalis Bambi Analerg
Placebo
Sugar pill manufactured to mimic Joalis Bambi Bronchi
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Joalis Bambi Analerg
Joalis Bambi Bronchi
Placebo
Sugar pill manufactured to mimic Joalis Bambi Analerg
Placebo
Sugar pill manufactured to mimic Joalis Bambi Bronchi
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 9-18 years
* signed Infromed Conset
Exclusion Criteria
* subjects with known intolerance or hypersensitivity to the components of food supplements
* subjects with alcohol abuse or drugs at the time of recruitment into the study
* subjects enrolled in another clinical trial in the last 1 month before enrollment in this study
* subjects in a situation which in the opinion of a doctor may interfere with optimal participation in the study or can pose a risk to the subjects
* pregnant girls, lactating girls and girls of childbearing age without adequate contraception
9 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DSC Services, s.r.o.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karel Chroust, RNDr., Ing., PhD.
Role: STUDY_DIRECTOR
DSC Services, s.r.o.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alergologická ambulance
Zlín, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Albert Drštička, MUDr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KS-2011-05-JOALIS
Identifier Type: -
Identifier Source: org_study_id